 Todos Medical Ltds CEO Gerald Commissiong has provided investors with an update on the companys CLIACAP-certified lab Provista Diagnostics, its 3CL Pharma majority-owned subsidiary progress, and plans to uplist the companys stock to a national stock exchange. In a statement, Commissiong said the companys lab Provista Diagnostics was getting further entrenched in the PCR testing business, expanding beyond coronavirus COVID-19 PCR testing to also test for pathogens such as urinary tract infection with PCR. 